Industry pressures Greek government for dual pricing
This article was originally published in Scrip
The Hellenic Association of Pharmaceutical Companies, SFEE, is behind a move to reintroduce dual pricing in Greece, said its president Dionysios Filiotis of Pharmaserve-Lilly. According to Mr Filiotis, drug prices would be based on the average of 16 Eurozone countries for one set of customers, and a "different" price for the social security funds. Mr Filiotis discussed the scheme as part of a wide-ranging interview with Scrip (see Face to Face scripintelligence.com 23 December 2010).